Kimryn Rathmell: Modernizing informed consent for clinical studies
Kimryn Rathmell, Director of the National Cancer Institute, shared the post on X:
“Join NCI Clinical Trials and Translational Research Advisory Committee tomorrow – we’ll discuss modernizing informed consent for clinical studies, community oncology research, and more. Agenda.
Join on 11/6 at 8:30am ET.”
More posts featuring Kimryn Rathmell
Kimryn Rathmell serves as the director of the National Cancer Institute. She is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers. She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023